• Developing Next Generation Treatments for

    CANINE AND HUMAN CANCER

  • What We Do

    We are developing novel therapeutic antibodies to treat canine and human cancer.

    Certain dog and human cancers are very similar. We leverage this knowledge to make a difference.

    We have a collaborative business model engaging world class partners.

  • Who We Are

    We have many years experience in cancer therapeutics. The founding team are:

    Dr Alan Clark

    Founder

    Innova Partnerships

    Founder

    Prof Ted Hupp

    Chairman, Advisory Board

    Prof David Argyle

    Advisory Board Member

    Prof Robin Fåhraeus

    Advisory Board Member

  • About You

    If you have an interest in partnering, licensing or acquiring our therapeutic antibody assets then we would like to hear from you.

  • Contact Us

    @luperacus

    Luperacus Ltd

    163 Bath Street

    Glasgow

    G2 4SQ

    Info@luperacus.com